Table 2 —Factors Associated with Unfavorable Outcomes in DM-COVID-19 Comorbidity Cases, Brazil (2020 – 2022).
Variables | Reference Category (Value = 0) | Coefficient | p-value | OR (95% CI) |
|---|---|---|---|---|
ICU Admission | No (0) | - | - | 1.0 |
Yes | 1.47 | < 0.01 | 4.37 (4.30—4.44) | |
Sex | Female (0) | - | - | 1.0 |
Male | 0.11 | < 0.01 | 1.12 (1.10—1.14) | |
Diagnostic Criterion: Laboratory | No (0) | - | - | 1.0 |
Yes | 0.77 | < 0.01 | 2.17 (1.98—2.38) | |
Diagnostic Criterion: Epidemiological | No (0) | - | - | 1.0 |
Yes | 0.62 | < 0.01 | 1.87 (1.54—2.26) | |
Diagnostic Criterion: Clinical | No (0) | - | - | 1.0 |
Yes | 0.43 | < 0.01 | 1.55 (1.32—1.81) | |
Diagnostic Criterion: Imaging | No (0) | - | - | 1.0 |
Yes | 0.35 | < 0.01 | 1.42 (1.16—1.74) | |
Age 1 to 5 years | No (0) | - | - | 1.0 |
Yes | −0.61 | 0.01 | 0.53 (0.31—0.88) | |
Age 6 to 19 years | No (0) | - | - | 1.0 |
Yes | −1.32 | < 0.01 | 0.26 (0.19—0.35) | |
Age 30 to 49 years | No (0) | - | - | 1.0 |
Yes | −0.17 | < 0.01 | 0.84 (0.79—0.89) | |
Age 50 to 59 years | No (0) | - | - | 1.0 |
Yes | 0.24 | < 0.01 | 1.28 (1.23—1.32) | |
Age 60 to 69 years | No (0) | - | - | 1.0 |
Yes | 0.65 | < 0.01 | 1.92 (1.86—1.98) | |
Age 70 to 79 years | No (0) | - | - | 1.0 |
Yes | 0.99 | < 0.01 | 2.71 (2.62—2.79) | |
Age 80 to 89 years | No (0) | - | - | 1.0 |
Yes | 1.30 | < 0.01 | 3.69 (3.56—3.83) | |
Age 90 years or older | No (0) | - | - | 1.0 |
Yes | 1.69 | < 0.01 | 5.44 (5.15—5.74) | |
Pregnant—1st Trimester | Yes (0) | - | - | 1.0 |
No | −1.14 | 0.01 | 0.31 (0.11—0.70) | |
Pregnant—2nd Trimester | Yes (0) | - | - | 1.0 |
No | −0.34 | 0.07 | 0.71 (0.48—1.02) | |
Pregnant—3rd Trimester | Yes (0) | - | - | 1.0 |
No | −0.95 | < 0.01 | 0.38 (0.28—0.50) | |
White Race/Color | No (0) | |||
Yes | 0.30 | < 0.01 | 1.35 (1.32—1.38) | |
Black Race/Color | No (0) | - | - | 1.0 |
Yes | 0.56 | < 0.01 | 1.75 (1.68—1.82) | |
Yellow Race/Color | No (0) | - | - | 1.0 |
Yes | 0.21 | < 0.01 | 1.24 (1.14—1.34) | |
Brown Race/Color | No (0) | - | - | 1.0 |
Yes | 0.48 | < 0.01 | 1.62 (1.58—1.66) | |
Indigenous Race/Color | No (0) | - | - | 1.0 |
Yes | 0.55 | < 0.01 | 1.74 (1.39—2.16) | |
No Schooling | No (0) | - | - | 1.0 |
Yes | 0.50 | < 0.01 | 1.65 (1.57—1.74) | |
Incomplete Elementary School | No (0) | - | - | 1.0 |
Yes | 0.38 | < 0.01 | 1.47 (1.43—1.51) | |
Complete Elementary School | No (0) | - | - | 1.0 |
Yes | 0.27 | < 0.01 | 1.32 (1.28—1.36) | |
Complete High School | No (0) | - | - | 1.0 |
Yes | 0.15 | < 0.01 | 1.16 (1.13—1.20) | |
Complete Higher Education | No (0) | - | - | 1.0 |
Yes | −0.08 | < 0.01 | 0.91 (0.88—0.95) | |
Comorbidities: Cardiopathy | No (0) | - | - | 1.0 |
Yes | 0.03 | < 0.01 | 1.04 (1.02—1.05) | |
Comorbidities: Down Syndrome | No (0) | - | - | 1.0 |
Yes | −0.07 | < 0.01 | 0.92 (0.91—0.94) | |
Comorbidities: Asthma | No (0) | - | - | 1.0 |
Yes | −0.05 | < 0.01 | 0.94 (0.93—0.96) | |
Comorbidities: Neurological Disease | No (0) | - | - | 1.0 |
Yes | 0.03 | < 0.01 | 1.03 (1.01—1.05) | |
Comorbidities: Renal Disease | No (0) | - | - | 1.0 |
Yes | 0.08 | < 0.01 | 1.09 (1.07—1.10) | |
Comorbidities: Obesity | No (0) | - | - | 1.0 |
Yes | 0.03 | < 0.01 | 1.03 (1.02—1.04) | |
Complete COVID-19 Vaccination Scheme | No (0) | - | - | 1.0 |
Yes | −0.28 | < 0.01 | 0.75 (0.73—0.77) |
